Corporate Governance and Structure - The company has established a unified action agreement among its actual controllers to maintain consistent voting behavior in board and shareholder meetings[129]. - The board of directors consists of 7 members, while the supervisory board has 3 members, and there are 7 senior management personnel[145]. - The company has established a clear and transparent cash dividend policy, ensuring the protection of minority shareholders' rights[142]. - The company has implemented a comprehensive assessment for determining the compensation of directors and senior management based on performance and responsibilities[150]. - The independent directors did not change during the reporting period, maintaining stability in governance[149]. - The company has continuously improved its governance structure and internal control management system in accordance with relevant laws and regulations[197]. - The governance mechanism provides adequate protection and equal rights for all shareholders, particularly minority shareholders[199]. - Major decisions such as amendments to the articles of association and share buybacks were conducted in accordance with established procedures[200]. Financial Performance - The company's operating revenue for 2023 was ¥477,980,447.37, a decrease of 15.32% compared to ¥564,459,985.78 in 2022[31]. - The net profit attributable to shareholders for 2023 was ¥22,569,060.74, down 63.75% from ¥62,252,904.51 in 2022[31]. - The gross profit margin for 2023 was 17.05%, significantly lower than 29.75% in 2022[31]. - Total assets increased by 13.15% to ¥953,964,753.93 at the end of 2023, compared to ¥843,106,834.73 at the end of 2022[33]. - The total liabilities decreased by 7.49% to ¥284,055,763.20 in 2023 from ¥307,037,554.75 in 2022[33]. - The net asset attributable to shareholders rose by 29.80% to ¥557,852,333.45 in 2023, compared to ¥429,763,900.32 in 2022[33]. - The basic earnings per share for 2023 was ¥0.2905, a decline of 67.33% from ¥0.8893 in 2022[31]. - The operating cash flow for 2023 was ¥3,744,942.71, a drastic decrease of 98.04% from ¥191,496,900.62 in 2022[33]. - The company reported a net non-recurring profit of ¥7,941,077.58 for 2023, compared to ¥6,318,642.88 in 2022[40]. - The company achieved a revenue of 477.98 million yuan in 2023, which is a key performance indicator[92]. Research and Development - During the reporting period, the company applied for 13 national patents, including 7 invention patents and 6 utility model patents, and was granted 17 patents, comprising 10 invention patents and 7 utility model patents[11]. - The company is in the industrial trial phase for the HPPO method of propylene oxide production, aiming to optimize catalyst preparation and achieve industry-leading performance[90]. - The company is developing a new type of catalyst for the synthesis of VCM using mercury-free ionic liquids, focusing on enhancing catalyst performance and reducing costs[90]. - The company is conducting research on a sodium sulfate solution purification process to effectively remove water-soluble organic impurities, achieving industrial-grade standards[90]. - The company is in the pilot stage for the production of bio-synthetic pharmaceutical intermediates, enriching its technological reserves in the biological field[91]. - The company is developing low-cost, high-quality enzyme nylon 56 salt production technology, laying the foundation for future industrialization[91]. - R&D expenditure for the period was 21,890,948.27 CNY, accounting for 4.58% of operating revenue, compared to 4.43% in the previous period[87]. - The total number of R&D personnel increased from 55 to 60, with the proportion of R&D staff in total employees rising from 15.71% to 17.44%[88]. - The company has formed partnerships with multiple research institutions to enhance its innovation capabilities and continuously invests in R&D[179]. Market Position and Strategy - The company aims to be a leading manufacturer of fine chemicals and a provider of green technology solutions, focusing on advanced green manufacturing technology[102]. - The company is positioned within a tight industrial chain, contributing to the development of regional industrial clusters such as the "China Spandex Valley" in Ningxia[101]. - The company is committed to innovation and technology development, with a focus on market-oriented product research and development planning[104]. - The company is aware of market fluctuations and plans to adapt its strategies accordingly to mitigate risks associated with market and industry cycles[106]. - The company has established a complete innovation system to enhance its innovation capabilities and mitigate risks associated with new business development[1]. - The company has a focus on green technology innovation and has increased R&D investment in advanced green manufacturing technologies[2]. Environmental and Social Responsibility - The company emphasizes social responsibility by focusing on technological innovation and contributing to clean production and green development in the chemical industry[98]. - The company emphasizes environmental protection and complies with relevant laws and regulations, implementing necessary environmental protection facilities to control pollutants effectively[99]. - The company has achieved compliance with hazardous waste management standards, ensuring proper disposal of waste materials[186]. - The company has established a strict management system for hazardous chemicals, ensuring compliance with relevant laws and regulations throughout the entire process from purchase to disposal[189]. - The company has implemented environmental protection facilities including SCR denitrification devices and wastewater treatment stations to enhance waste treatment capabilities[188]. Shareholder and Capital Management - The company raised ¥141,768,000.00 through the public issuance of 13.2 million shares, resulting in a net fundraising amount of ¥121,525,434.00 after deducting issuance costs[72]. - The company has maintained a consistent strategy in its shareholder structure, with no new significant shareholders introduced during the reporting period[128]. - The company has not faced any major litigation or arbitration matters during the reporting period[4]. - The company has fulfilled all disclosed commitments without any overdue obligations[118]. - The company has not proposed any cash dividend distribution plan despite having positive undistributed profits during the reporting period[144]. - The company has established a training system to enhance employee skills and align them with strategic goals[153]. Operational Performance - The company’s production capacity for toluene oxidation series products increased by 27% year-on-year due to technological upgrades[46]. - The company’s production of benzyl alcohol, a key product, is positioned at the forefront of the industry, utilizing a unique toluene oxidation method[50]. - The company’s THF production process integrates advanced technologies such as reaction distillation and heat coupling, effectively managing pollutants[175]. - The company has achieved industrialization of self-developed technologies in the fields of tetrahydrofuran and toluene oxidation, producing and selling related fine chemicals[188]. - The company has implemented comprehensive safety management measures, including regular safety inspections and training, to ensure a safe production environment[183].

证券代码：832471 证券简称：美邦科技 公告编号：2024-041 河北美邦工程科技股份有限公司 会计师事务所履职情况评估报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 河北美邦工程科技股份有限公司聘请大华会计师事务所（特殊普通合伙） （以下简称"大华"）作为公司 2023 年度审计机构，根据《国有企业、上市公 司选聘会计师事务所管理办法》，公司董事会对大华 2023 年度审计工作的履职 情况进行了评估，具体情况如下: 一、会计师事务所的基本情况 （一）资质条件 会计师事务所名称：大华会计师事务所（特殊普通合伙） 成立日期：2012 年 2 月 9 日 组织形式：特殊普通合伙 注册地址：北京市海淀区西四环中路 16 号 7 号楼 1101 首席合伙人：梁春 2022 年度末合伙人数量：272 人 2022 年收入总额（经审计）：332,731.85 万元 2022 年审计业务收入（经审计）：307,355.10 万元 2022 年证券业务收入（经审计）：138,862.04 万元 2022 年 ...

证券代码：832471 证券简称：美邦科技 公告编号：2024-029 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 4 月 23 日 2.会议召开地点：公司会议室 4.发出董事会会议通知的时间和方式：2024 年 4 月 12 日以邮件方式发出 5.会议主持人：董事长高文杲 6.会议列席人员：监事会成员、董事会秘书及公司高级管理人员 河北美邦工程科技股份有限公司 第四届董事会第二次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 3.会议召开方式：现场及通讯 1.议案内容： 根据《公司法》和《公司章程》的规定，由公司总经理代表管理层汇报 2023 年度经营工作情况。 2.议案表决结果：同意 7 票；反对 0 票；弃权 0 票。 3.回避表决情况： 本议案无需回避表决。 7.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关 法律法规以及公司内部治理规则的规定，所作决议合法有效。 （二）会议出席情况 会议应出席董事 ...

Financial Performance - Operating revenue for Q1 2024 reached CNY 120,656,773.92, a 30.71% increase year-on-year[10] - Net profit attributable to shareholders surged by 210.47% to CNY 2,464,084.47 compared to a loss of CNY 2,230,549.84 in the same period last year[10] - The company's operating profit for Q1 2024 was CNY 6,813,053.27, compared to a loss of CNY 2,891,692.37 in Q1 2023, indicating a turnaround in profitability[37] - Net profit for Q1 2024 was CNY 6,227,468.62, contrasting with a net loss of CNY 1,730,152.92 in Q1 2023, showcasing a substantial improvement in financial performance[37] - Total revenue for Q1 2024 reached CNY 120,656,773.92, a significant increase from CNY 92,305,375.87 in Q1 2023, representing a growth of approximately 30.8%[36] Cash Flow - The net cash flow from operating activities improved by 189.33% to CNY 12,800,528.85, compared to a negative cash flow of CNY 14,329,491.78 in Q1 2023[12] - The company reported cash inflows from investment activities of ¥10,178,018.58 million in Q1 2024, a decrease from ¥49,918,493.31 million in Q1 2023[43] - The net cash flow from financing activities was -¥872,597.52 million in Q1 2024, compared to -¥4,817,988.25 million in Q1 2023, indicating a reduction in financing losses[43] - Net cash flow from operating activities for Q1 2024 was $16,301,051.07, compared to a negative cash flow of -$5,229,998.71 in Q1 2023, indicating a strong turnaround[46] Assets and Liabilities - Total assets increased by 2.55% to CNY 978,257,548.79 compared to the end of last year[10] - The company's asset-liability ratio increased to 31.39% from 29.78% at the end of the previous year[10] - The total liabilities increased to ¥307,076,410.24 from ¥284,055,763.20, reflecting a rise of about 8.1%[32] - The total value of assets under restriction due to bank loans is CNY 162,255,326.18, which accounts for 16.58% of total assets[27] Shareholder Information - The total number of shares held by the top ten shareholders is 55,975,532, representing 67.27% of the total shares[18] - The largest shareholder, Gao Wengao, holds 23,022,000 shares, accounting for 27.67% of the total shares[17] - The company plans to repurchase shares at a price not exceeding CNY 12.80 per share, with a total repurchase fund of no less than CNY 10,000,000 and no more than CNY 20,000,000[24] Research and Development - Research and development expenses for Q1 2024 were CNY 4,618,555.66, slightly down from CNY 4,472,336.55 in Q1 2023, suggesting stable investment in innovation[36] - Research and development expenses increased to ¥648,439.09 million in Q1 2024 from ¥565,117.66 million in Q1 2023, showing a commitment to innovation[40] Other Financial Metrics - The weighted average return on equity based on net profit attributable to shareholders was 0.44%, up from -0.52% in the same period last year[10] - Basic and diluted earnings per share for Q1 2024 were both CNY 0.0296, a recovery from a loss of CNY 0.0319 in Q1 2023[38] - The company experienced a credit impairment loss of CNY -1,128,501.04 in Q1 2024, worsening from CNY -1,808,459.05 in Q1 2023, highlighting ongoing challenges in credit quality[37] Inventory and Receivables - The company reported a significant increase in accounts receivable financing, up 98.39% to CNY 32,864,205.75 due to an increase in notes receivable[11] - Inventory shares increased by 772.35% to CNY 7,058,490.48 as the company repurchased shares[11] - Accounts receivable slightly decreased to ¥38,507,032.89 from ¥39,093,526.06, a reduction of approximately 1.5%[30] Commitments and Legal Matters - The company has no new commitments as of the reporting period, and all previously disclosed commitments are being fulfilled normally[25] - The company has no litigation or arbitration matters during the reporting period[21] - The company has no shareholder or related party fund occupation or transfer issues[21] - The company has no new pledges or judicial freezes on shares held by shareholders[19]

证券代码：832471 证券简称：美邦科技 公告编号：2024-030 河北美邦工程科技股份有限公司 第四届监事会第二次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、会议召开和出席情况 （一）会议召开情况 5.会议主持人：监事会主席马记 6.召开情况合法、合规、合章程性说明： 本次会议的召开、召集和表决程序符合《公司法》和《公司章程》有关法 律法规以及公司内部治理规则的规定，所作决议合法有效。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于 2023 年度监事会工作报告的议案》 1.议案内容： 根据《公司法》和《公司章程》的规定，由公司监事会主席代表监事会汇 报 2023 年度监事会工作情况。 2.议案表决结果：同意 3 票；反对 0 票；弃权 0 票。 1.会议召开时间：2024 年 4 月 23 日 2.会议召开地点：公司会议室 3.会议召开方式：现场及通讯 4.发出监事会会议通知的时间和方式：2024 年 4 月 ...

证券代码：832471 证券简称：美邦科技 公告编号：2024-035 河北美邦工程科技股份有限公司 2023 年度募集资金存放与实际使用情况的专项报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、募集资金基本情况 | 新材料有限公司 | 部 | | | | --- | --- | --- | --- | | | 合计 | - | 231.35 | 注：截至本专项报告公告之日，公司存储于北京银行股份有限公司石家庄谈固 大街支行、中国银行乌海分行营业部的募集资金余额已全部投入募投项目，公 司募集资金已使用完毕并于 2024 年 4 月完成募集资金专户注销。 二、募集资金管理情况 为规范公司募集资金管理、保护投资者权益，公司根据《北京证券交易 所股票上市规则（试行）》等相关规定以及公司制定的《募集资金管理制 度》，对募集资金进行专户存储管理，并已与保荐机构、存放募集资金的银 行签署了募集资金监管协议。 报告期内，公司严格按照《募集资金管理制度》相关规定执行募集资金 的存放、管理、使用，募集资金的存放 ...

河北美邦工程科技股份有限公司 内部控制鉴证报告 大华核字[2024]0011010514 号 大 华 会 计 师 事 务 所 (特 殊 普 通 合 伙 ) Da Hua Certified PublicAccountants（Special General Partnership） 河北美邦工程科技股份有限公司 内部控制鉴证报告 （截止 2023 年 12 月 31 日） 目 录 页 次 一、 内部控制鉴证报告 1-3 二、 河北美邦工程科技股份有限公司内部控制自 我评价报告 1-15 大华会计师事务所（特殊普通合伙） 北京市海淀区西四环中路 16 号院 7 号楼 12 层 [100039] 电话：86 (10) 5835 0011 传真：86 (10) 5835 0006 www.dahua-cpa.com 内 部 控 制 鉴 证 报 告 大华核字[2024]0011010514 号 河北美邦工程科技股份有限公司全体股东： 我们接受委托，鉴证了后附的河北美邦工程科技股份有限公司 （以下简称美邦科技公司）管理层编制的《内部控制自我评价报告》 涉及的 2023 年 12 月 31 日与财务报表相关的内部控制有效 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 根据《上市公司独立董事管理办法》《北京证券交易所上市公司持续监管指 引第 1 号——独立董事》等相关规定，并结合独立董事向董事会提供的关于独 立性情况的自查报告及相关资料，河北美邦工程科技股份有限公司（以下简称 "公司"）董事会就公司在任独立董事沈晓冬、冯文英、林金锋的独立性情况 进行评估并出具如下专项意见： （一）独立董事及其配偶、父母、子女、具有主要社会关系的人员未在公 司或公司附属企业任职； （二）独立董事及其配偶、父母、子女未直接或间接持有公司已发行股份 百分之一以上，不是公司前十名股东中的自然人股东； （三）独立董事及其配偶、父母、子女不是直接或间接持有公司已发行股 份百分之五以上的股东，未在公司前五名股东任职； 证券代码：832471 证券简称：美邦科技 公告编号：2024-039 河北美邦工程科技股份有限公司 董事会关于独立董事独立性自查情况的专项报告 综上，董事会认为公司在任独立董事具备任职条件，不存在影响其独立性 的情形。 河北美邦工程科 ...

证券代码：832471 证券简称：美邦科技 公告编号：2024-042 河北美邦工程科技股份有限公司 关于使用部分闲置自有资金进行现金管理的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、 委托理财概述 （一） 委托理财目的 为提高资金使用效率，增加资金使用效益，公司根据资金预算使用情况， 在确保正常经营所需流动资金及资金安全的情况下，利用部分闲置自有资金购 买低风险、流动性高的银行理财产品，保障闲置资金的投资收益。 （二） 委托理财金额和资金来源 本次现金管理运用公司及控股子公司闲置自有资金。 （三） 委托理财方式 1、 预计委托理财额度的情形 公司拟使用单笔不超过 3,000 万元，同时累计不超过 15,000 万元的闲置 自有资金购买安全性高、流动性好的理财产品。在上述额度内，资金可以滚动 使用，理财取得的收益可进行再投资，再投资的金额不包含在上述额度以内。 （四） 委托理财期限 根据《北京证券交易所股票上市规则（试行）》有关规定，授权期限自股东 大会审议通过之日起 12 个月内有效，授 ...

中国国际金融股份有限公司 关于河北美邦工程科技股份有限公司 2023 年度募集资金存放与使用情况的专项核查报告 中国国际金融股份有限公司（以下简称"中金公司"或"保荐机构"）作为 河北美邦工程科技股份有限公司（以下简称"美邦科技"或"公司"）向不特定 合格投资者公开发行股票并在北京证券交易所上市的保荐机构，对美邦科技履行 持续督导义务。根据《证券发行上市保荐业务管理办法》《北京证券交易所股票 上市规则（试行）》《北京证券交易所上市公司持续监管办法（试行）》《北京证券 交易所证券发行上市保荐业务管理细则》等相关法律、法规和规范性文件的规定， 中金公司及其指定保荐代表人对美邦科技 2023 年度募集资金存放与使用情况进 行了专项核查，核查情况与意见如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位时间 2023 年 4 月 24 日，中国证券监督管理委员会出具《关于同意河北美邦工程 科技股份有限公司向不特定合格投资者公开发行股票注册的批复》（证监许可 [2023]952 号），同意公司向不特定合格投资者公开发行股票的注册申请。公司股 票于2023年5月25日在北京证券交易所上市。公司本次股票发行数量为 ...